Verdence Capital Advisors LLC Sanofi Transaction History

Verdence Capital Advisors LLC

$1.66 Billion
Q3 2025

A detailed history of Verdence Capital Advisors LLC transactions in Sanofi stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 34,487 shares of SNY stock, worth $1.79 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

34,487

Previous 34,379 0.31%

Holding current value

$1.79 Million

Previous $1.66 Million 1.99%

% of portfolio

0.1%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	BUY	$45.07 - $51.35 $4,867 - $5,545	108 Added 0.31%	34,487 $1.63 Million
Q2 2025 Jul 25, 2025	SELL	$47.62 - $55.44 $7,952 - $9,258	-167 Reduced 0.48%	34,379 $1.66 Million
Q1 2025 May 02, 2025	BUY	$48.15 - $59.42 $175,121 - $216,110	3,637 Added 11.77%	34,546 $1.92 Million
Q4 2024 Feb 06, 2025	BUY	$45.89 - $57.31 $17,713 - $22,121	386 Added 1.26%	30,909 $1.49 Million
Q3 2024 Nov 01, 2024	BUY	$48.54 - $58.53 $37,084 - $44,716	764 Added 2.57%	30,523 $1.76 Million

Q2 2024 Jul 25, 2024	BUY	$45.39 - $50.36 $341,877 - $379,311	7,532 Added 33.89%	29,759 $1.44 Million
Q1 2024 Apr 25, 2024	BUY	$45.75 - $52.48 $343,582 - $394,124	7,510 Added 51.03%	22,227 $1.08 Million
Q4 2023 Jan 31, 2024	SELL	$43.13 - $54.79 $161,780 - $205,517	-3,751 Reduced 20.31%	14,717 $731,000
Q3 2023 Oct 25, 2023	BUY	$50.95 - $55.2 $84,627 - $91,687	1,661 Added 9.88%	18,468 $990,000
Q2 2023 Jul 28, 2023	BUY	$50.45 - $57.18 $195,392 - $221,458	3,873 Added 29.94%	16,807 $905,000
Q1 2023 Apr 24, 2023	BUY	$45.86 - $54.45 $593,153 - $704,256	12,934 New	12,934 $703,000
Q3 2022 Nov 15, 2022	SELL	$37.22 - $100.5 $680,939 - $1.84 Million	-18,295 Reduced 50.05%	18,255 $694,000
Q2 2022 Aug 08, 2022	BUY	$48.99 - $57.46 $94,697 - $111,070	1,933 Added 5.58%	36,550 $1.83 Million
Q1 2022 May 02, 2022	BUY	$48.48 - $53.65 $82,416 - $91,205	1,700 Added 5.16%	34,617 $1.78 Million
Q4 2021 Jan 26, 2022	BUY	$47.07 - $52.35 $119,699 - $133,126	2,543 Added 8.37%	32,917 $1.65 Million
Q3 2021 Nov 12, 2021	BUY	$47.89 - $53.12 $89,266 - $99,015	1,864 Added 6.54%	30,374 $1.46 Million
Q2 2021 Aug 06, 2021	BUY	$49.36 - $54.25 $64,365 - $70,742	1,304 Added 4.79%	28,510 $1.5 Million
Q1 2021 May 11, 2021	SELL	$45.46 - $50.51 $30,867 - $34,296	-679 Reduced 2.44%	27,206 $1.35 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $23,420 - $26,687	517 Added 1.89%	27,885 $1.36 Million
Q3 2020 Nov 09, 2020	SELL	$49.47 - $53.77 $17,116 - $18,604	-346 Reduced 1.25%	27,368 $1.37 Million
Q2 2020 Aug 11, 2020	BUY	$42.91 - $52.5 $51,577 - $63,105	1,202 Added 4.53%	27,714 $1.42 Million
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $100,524 - $136,589	2,644 Added 11.08%	26,512 $1.16 Million
Q4 2019 Feb 03, 2020	BUY	$44.25 - $50.86 $65,224 - $74,967	1,474 Added 6.58%	23,868 $1.2 Million
Q3 2019 Mar 06, 2020	BUY	$40.34 - $46.64 $5,728 - $6,622	142 Added 0.64%	22,394 $1.04 Million
Q2 2019 Mar 02, 2020	BUY	$40.43 - $44.3 $255,800 - $280,286	6,327 Added 39.73%	22,252 $963,000
Q1 2019 Mar 02, 2020	BUY	$40.83 - $45.43 $650,217 - $723,472	15,925 New	15,925 $705,000
Q3 2018 Feb 25, 2020	SELL	$40.0 - $44.84 $791,200 - $886,935	-19,780 Closed	0 $0
Q2 2018 Feb 11, 2020	SELL	$37.63 - $41.22 $25,475 - $27,905	-677 Reduced 3.31%	19,780 $791,000
Q1 2018 Jan 30, 2020	BUY	$38.98 - $45.76 $152,801 - $179,379	3,920 Added 23.7%	20,457 $820,000
Q4 2017 Jan 30, 2020	BUY	$42.86 - $50.61 $708,775 - $836,937	16,537	16,537 $711,000

Others Institutions Holding SNY

# of Institutions

830

Shares Held

250M

Call Options Held

2.45M

Put Options Held

2.51M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $130B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Sanofi Transaction History